US Patent Number

4428883

Publication Date

1-31-1984

Abstract

The invention provides a novel method of administering selected known adrenergic β-receptor blocking agents, such as dichloroisoproterenol, pronethalol, sotalol and alprenolol, which are of use in the treatment of angina pectoris, arrhythmias, hypertension and other cardiac conditions, and migraine. The invention further provides novel dosage forms of those β-blockers which are adapted for nasal administration and which include solutions, suspensions, gels and ointments.

Assignees

University of Kentucky Research Foundation, Lexington, Ky.

Application Number

241,413

Filing Date

03/06/1981

Share

COinS